JENNIFER SUSANNE TAYLOR

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant CLAYTON, NC NPI 1780896589

General Payments — all program years on this page

$7,668.81

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 467
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $772.14 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $772.1442

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $3,137.63206
2022 $2,180.95132
2023 $1,578.0987
2024 $772.1442

Records — PY2024 (42)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078073534 Janssen Pharmaceuticals, Inc $22.83 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100256576 Novo Nordisk Inc $15.24 01/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100268856 Novo Nordisk Inc $21.94 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100299509 Novo Nordisk Inc $18.44 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100347244 Novo Nordisk Inc $19.70 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100493319 Novo Nordisk Inc $22.38 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100501047 Novo Nordisk Inc $20.14 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100510873 Novo Nordisk Inc $18.24 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100540226 Novo Nordisk Inc $12.92 02/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100562253 Novo Nordisk Inc $14.57 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100599093 Novo Nordisk Inc $21.26 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100604264 Novo Nordisk Inc $19.47 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100650713 Novo Nordisk Inc $18.46 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105857324 AstraZeneca Pharmaceuticals LP $14.79 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290594 ABBVIE INC. $3.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290596 ABBVIE INC. $14.22 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290598 ABBVIE INC. $23.95 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290600 ABBVIE INC. $28.34 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290602 ABBVIE INC. $24.89 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290604 ABBVIE INC. $23.74 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290606 ABBVIE INC. $22.99 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290608 ABBVIE INC. $16.51 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290610 ABBVIE INC. $14.25 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290612 ABBVIE INC. $22.17 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290614 ABBVIE INC. $11.74 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108290616 ABBVIE INC. $13.25 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116991892 Medtronic, Inc. $16.66 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116991894 Medtronic, Inc. $25.29 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117698496 Amgen Inc. $15.68 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118153831 Boehringer Ingelheim Pharmaceuticals, Inc. $14.01 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119197916 Otsuka America Pharmaceutical, Inc. $23.66 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119197918 Otsuka America Pharmaceutical, Inc. $22.24 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127050917 Kyowa Kirin, Inc. $23.58 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127050919 Kyowa Kirin, Inc. $26.32 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127050921 Kyowa Kirin, Inc. $19.93 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131447799 PFIZER INC. $14.04 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135656561 Lilly USA, LLC $13.76 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135656563 Lilly USA, LLC $13.50 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135699558 Lilly USA, LLC $18.41 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135715370 Lilly USA, LLC $13.73 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141738867 Merck Sharp & Dohme LLC $15.80 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143614103 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.10 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.